Health Innovation Leaders Advocate for Enhanced Accountability and Safety Standards in Wellness Technology

Lindsay O’Neill-O’Keefe, CEO of Wellness Eternal and member of the Forbes Business Council, has published her first Forbes article, exploring how the rapid expansion of wellness and health technology must be balanced with greater oversight, transparency, and evidence-based safety protocols to build lasting trust. The article draws inspiration from trusted voices such as Dr. Jason Sonners of HBOT USA, Joseph Krieger of Boston BioLife, and research from the Biohacking Index, which evaluates efficacy across emerging health solutions.

O’Neill-O’Keefe highlights innovators like Oxygen Health Systems, a U.S.-based manufacturer recognized for advancing rigorous safety standards in Hyperbaric Oxygen Therapy (HBOT). With more than 40 chamber models ranging from $8,000 to $80,000+, Oxygen Health Systems has made safe HBOT technology more accessible in both clinical and home settings. She emphasizes that entrepreneurs and health leaders are increasingly seeking recovery tools and technologies that reflect the rigor of clinical medicine, pointing to the work of experts like Dr. Sonners, whose published HBOT research shows the importance of differentiating between safe, medically guided protocols versus under-regulated applications.

Similarly, Joseph Krieger’s physician education initiatives at Boston BioLife underscore the role of clinical data and practitioner training in reducing risk as wellness technologies scale. The article stresses that true innovation must be paired with responsibility and integrity, calling for a new standard where rapid growth is matched by safety, transparency, and trust. O’Neill-O’Keefe asserts that safety protocols, efficacy, and leadership are not optional but foundational to trust, which is why she relies on credible experts and validated data, such as those found in the Biohacking Index.

The implications of this call for accountability are significant, as the health and wellness sector continues to expand with new technologies that impact consumer safety and public trust. Without enhanced oversight and evidence-based approaches, the risk of misinformation and unsafe practices could undermine innovation. By advocating for third-party validation and leadership-driven standards, O’Neill-O’Keefe’s article serves as a crucial reminder that sustainable growth in health innovation depends on building a foundation of trust through transparency and rigorous safety measures.